While cardiovascular magnetic resonance (MR) has become the noninvasive tool of choice
for the assessment of myocardial viability and for the detection of acute myocardial edema …

The increasing use of cardiovascular magnetic resonance (CMR) is based on its capability
to perform biventricular function assessment and tissue characterization without radiation …

Myocardial T1 mapping by cardiovascular magnetic resonance (CMR) is a key emerging
biomarker for quantification of myocardial disease. Native myocardial T1 changes with fat …

Myocardial native T1 and extracellular volume fraction (ECV) mapping have emerged as
cardiac magnetic resonance biomarkers providing unique insight into cardiac …

Cardiovascular magnetic resonance (CMR) is a versatile imaging modality that enables
aetiological assessment and provides additional information to that of standard …

Cardiovascular magnetic resonance is a well-established tool for the quantification of focal
fibrosis. With the introduction of T1 mapping, diffuse myocardial processes can be detected …

Myocardial fibrosis can arise from a range of pathological processes and its presence
correlates with adverse clinical outcomes. Cardiac magnetic resonance (CMR) can provide …

Quantitative myocardial and blood T 1 have recently achieved clinical utility in numerous
pathologies, as they provide non-invasive tissue characterization with the potential to …

Abstract Cardiovascular Magnetic Resonance is increasingly used to differentiate the
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …

Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …